Abstract
The global generics industry is about to embark on a decade of seismic change, and the impact to both patients and health-care systems cannot be overstated. This paper provides an overview of the global pharmaceutical market in the context of today's economic crisis, and a corresponding outline of key trends shaping the global generics market. It then focuses-in on an examination of the trend toward centralized contracting and how it will benefit those generics manufacturers with a broad portfolio and low-cost manufacturing base.
Get full access to this article
View all access options for this article.